A multicenter, double-blind, placebo-controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles

导出原文传递

翻译打印收藏纠错

作者： Smith,S.R. ^[1] ; Munavalli,G. ^[2] ; Weiss,R. ^[3] ; Maslowski,J.M. ^[4] ; Hennegan,K.P. ; Novak,J.M.

作者单位： Fibrocell Technologies Inc., Exton, PA, United States ^[1] CBR International Corp., Boulder, CO, United States ^[2] Maryland Laser, Skin and Vein Institute, Hunt Valley, MD, United States ^[3] Division of Dermatology, University of California at Los Angeles California, Skin Care and Laser ^[4]

发布时间 2020-07-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Dermatologic surgery

2012年38卷7 Pt.II期

1234-1243页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A multicenter, double-blind, placebo-controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles

Dermatologic surgery

相似文献

Dermatologic surgery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A multicenter, double-blind, placebo-controlled trial of autologous fibroblast therapy for the treatment of nasolabial fold wrinkles

Dermatologic surgery

相似文献

Dermatologic surgery

相关期刊

检索历史清除